Details of the Drug

General Information of Drug (ID: DM9FZYT)

Drug Name
Spesolimab
Synonyms BI-655130
Indication
Disease Entry ICD 11 Status REF
Psoriasis vulgaris EA90 Approved [1]
Palmoplantar pustulosis EA90.42 Phase 2 [2]
Plaque psoriasis EA90.0 Phase 2 [2]
Affected Organisms
Humans and other mammals
ATC Code
L04AC22: Spesolimab
L04AC: Interleukin inhibitors
L04A: IMMUNOSUPPRESSANTS
L04: IMMUNOSUPPRESSANTS
L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Cross-matching ID
UNII
5IB2J79MCX
DrugBank ID
DB15626
TTD ID
D0W9YW
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
IL-1 receptor-like 2 (IL1RL2) TTUS18T ILRL2_HUMAN Antagonist [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 761244.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)